JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD

WKN A2PR4L | ISIN LU2050612154 |  Fonds
Factsheet
09.04.25
74,01 USD-6,87 % (-5,46)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU2384387564 CPR Invest - MedTech - A HUF - Acc +2,87 % +15,57 % 0,04
2 BE0170813936 KBC Equity Fund Medical Technologies Classic -0,55 % +12,37 % -0,23
3 LU0462856898 BGF World Healthscience Fund X2 USD -3,41 % +14,68 % -0,39
4 BE6323644201 KBC Equity Fund We Care Responsible Investing Classic Shares K&H HUF -2,83 % +12,66 % -0,40
5 LU2036818289 CPR Invest - MedTech - H USD - Acc +1,07 % +14,42 % -0,08
318 LU2050612154 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - USD -29,16 % +23,76 % -1,32
439 LU2425425506 Candriam Equities L Oncology, V - Capitalisation -14,94 % +12,44 % -1,38
440 LU1864481624 Candriam Equities L Oncology, C-H - Capitalisation -17,15 % +13,71 % -1,42
441 LU1864482515 Candriam Equities L Oncology, I - Capitalisation -15,21 % +12,45 % -1,41
442 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -15,29 % +12,45 % -1,41
443 LU1864482606 Candriam Equities L Oncology, N-H - Capitalisation -17,48 % +13,70 % -1,44